{
    "Trade/Device Name(s)": [
        "Elecsys Troponin T Gen 5",
        "Troponin T Gen 5"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K201441",
    "Predicate Device Reference 510(k) Number(s)": [
        "K162895"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MMI"
    ],
    "Summary Letter Date": "December 2, 2020",
    "Summary Letter Received Date": "December 3, 2020",
    "Submission Date": "September 15, 2021",
    "Regulation Number(s)": [
        "21 CFR 862.1215"
    ],
    "Regulation Name(s)": [
        "Creatine Phosphokinase/Creatine Kinase Or Isoenzymes Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Cardiac Troponin T (cTnT)"
    ],
    "Specimen Type(s)": [
        "Lithium heparin plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "cobas e immunoassay analyzers",
        "cobas e 601 analyzer",
        "cobas e 801 analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemiluminescent immunoassay (ECLIA)",
        "Sandwich immunoassay"
    ],
    "Methodologies": [
        "Immunoassay",
        "Sandwich immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Roche Diagnostics Elecsys Troponin T Gen 5 assay, an electrochemiluminescent immunoassay for cardiac troponin T measurement on cobas e analyzers",
    "Indications for Use Summary": "Immunoassay for the in vitro quantitative determination of cardiac troponin T (cTnT) in lithium heparin plasma to aid in diagnosis of myocardial infarction, intended for use on cobas e immunoassay analyzers",
    "fda_folder": "Clinical Chemistry"
}